Among them, type I interferons and Toll-like receptors regulate PD-1 and its ligand PD-L1 expression by activating NF-κB or STAT1, playing a crucial role in SLE pathogenesis [51]. This evidence concerns the gene CD274 and systemic lupus erythematosus.